CalciMedica Depreciation & Amortization Growth & History (CALC)
CalciMedica's depreciation and amortization was $46,000 for fiscal 2025.
View full CalciMedica company overviewCalciMedica annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $46,000 | −$12,000 | −20.69% |
| 2024 | 2024-12-31 | $58,000 | $0 | 0.00% |
| 2023 | 2023-12-31 | $58,000 | $6,000 | +11.54% |
| 2022 | 2022-12-31 | $52,000 | −$467,000 | −89.98% |
| 2021 | 2021-12-31 | $519,000 | $124,000 | +31.39% |
| 2020 | 2020-12-31 | $395,000 | $92,000 | +30.36% |
| 2019 | 2019-12-31 | $303,000 | — | — |
CalciMedica quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7,000 | −$7,000 | −50.00% |
| Q1 2026 | 2026-03-31 | $7,000 | −$8,000 | −53.33% |
| Q4 2025 | 2025-12-31 | $5,000 | — | — |
| Q3 2025 | 2025-09-30 | $12,000 | −$3,000 | −20.00% |
| Q2 2025 | 2025-06-30 | $14,000 | −$1,000 | −6.67% |
| Q1 2025 | 2025-03-31 | $15,000 | $0 | 0.00% |
| Q3 2024 | 2024-09-30 | $15,000 | $3,000 | +25.00% |
| Q2 2024 | 2024-06-30 | $15,000 | $1,000 | +7.14% |
| Q1 2024 | 2024-03-31 | $15,000 | $2,000 | +15.38% |
| Q3 2023 | 2023-09-30 | $12,000 | −$1,000 | −7.69% |
| Q2 2023 | 2023-06-30 | $14,000 | $1,000 | +7.69% |
| Q1 2023 | 2023-03-31 | $13,000 | $0 | 0.00% |
| Q3 2022 | 2022-09-30 | $13,000 | −$123,000 | −90.44% |
| Q2 2022 | 2022-06-30 | $13,000 | −$116,000 | −89.92% |
| Q1 2022 | 2022-03-31 | $13,000 | −$105,000 | −88.98% |
| Q3 2021 | 2021-09-30 | $136,000 | $40,000 | +41.67% |
| Q2 2021 | 2021-06-30 | $129,000 | $34,000 | +35.79% |
| Q1 2021 | 2021-03-31 | $118,000 | $25,000 | +26.88% |
| Q3 2020 | 2020-09-30 | $96,000 | — | — |
| Q2 2020 | 2020-06-30 | $95,000 | — | — |
| Q1 2020 | 2020-03-31 | $93,000 | — | — |
CalciMedica depreciation and amortization trends
Over the last five fiscal years, CalciMedica's depreciation and amortization decreased from $395,000 to $46,000, a change of −$349,000. The latest reported quarter, Q2 2026, shows $7,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CalciMedica source filings ↗